Browsing by Author "Godspower Akpomiemie"
Now showing 1 - 7 of 7
- Results Per Page
- Sort Options
Item Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function a secondary analysis from the ADVANCE trial in South Africa(INT AIDS SOCIETY) Jennifer Manne-Goehler; June Fabian; Simiso Sokhela; Godspower Akpomiemie; N Rahim; Samanta Lalla-Edward; Alana Brennan; M Siedner; A Hill; Willem VenterItem Determinants of early change in serum creatinine after initiation of dolutegravirbased antiretroviral therapy in South Africa(WILEY-BLACKWELL) R Mpofu; A Kawuma; R Wasmann; Godspower Akpomiemie; Nomathemba Chandiwana; Simiso Sokhela; Willem Venter; Michelle Moorhouse; P Denti; E et alItem Final 192Week Efficacy and Safety Results of the ADVANCED Trial Comparing 3 Firstline Antiretroviral RegimensSimiso Sokhela; Willem Venter; B Bosch; J Woods; Godspower Akpomiemie; Nomathemba Chandiwana; Angela Tembo; Lucas Hermans; Shane Norris; Lee Fairlie; E et alItem Fine 192week efficacy and safety results of the ADVANCE trial comparing 3 firstline Antiretroviral RegimesSimiso Sokhela; Willem Venter; B Bosch; J Woods; K McCann; Godspower Akpomiemie; Nomathemba Chandiwana; Nonkululeko Mashabane; Angela Tembo; Samanta Lalla-Edward; Lucas Hermans; Lee Fairlie; A Vos; Shane Norris; N Arupallan; et al et alItem Lowdose ritonavirboosted darunavir once daily versus ritonavirboosted lopinavir for participants with less than 50 HIV RNA copies per MlWRHI 052 a randomised openlabel phase 3 noninferiority trialWillem Venter; Michelle Moorhouse; Simiso Sokhela; Celicia Serenata; Godspower Akpomiemie; Ambar Qavi; Nonkululeko Mashabane; Natasha Arulappan; Joel Weibo Sim; et al et al; Tom Boyles; Sarah StaceyItem Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population(OXFORD UNIV PRESS) R Griesel; P Sinxadi; A Kawuma; J Joska; Simiso Sokhela; Godspower Akpomiemie; Willem Venter; E et alItem Weight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTG(OXFORD UNIV PRESS INC) B Bosch; Godspower Akpomiemie; Nomathemba Chandiwana; Simiso Sokhela; A Hill; K McCann; A Qavi; E et al; Willem Venter